BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 373530 Cc1cc(N)nc(C)c1CNC(=O)c1ccc(Cn2ccc3ccccc3c2=O)o1 InChI=1S/C23H22N4O3/c1-14-11-21(24)26-15(2)19(14)12-25-22(28)20-8-7-17(30-20)13-27-10-9-16-5-3-4-6-18(16)23(27)29/h3-11H,12-13H2,1-2H3,(H2,24,26)(H,25,28) PCYFGXWDBASQBM-UHFFFAOYSA-N 211969 US9290485, 1 Plasma kallikrein Human 810 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211969&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081186 329587846 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373531 Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccccc2)n(C)n1 InChI=1S/C19H22N6O/c1-12-9-16(20)22-13(2)15(12)11-21-19(26)18-23-17(25(3)24-18)10-14-7-5-4-6-8-14/h4-9H,10-11H2,1-3H3,(H2,20,22)(H,21,26) ZUDXQKDTYUIMKT-UHFFFAOYSA-N 211970 US9290485, 2 Plasma kallikrein Human 7670 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211970&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836122 329587847 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373532 Cc1cc(N)nc(C)c1CNC(=O)c1cc(Cc2ccccc2)no1 InChI=1S/C19H20N4O2/c1-12-8-18(20)22-13(2)16(12)11-21-19(24)17-10-15(23-25-17)9-14-6-4-3-5-7-14/h3-8,10H,9,11H2,1-2H3,(H2,20,22)(H,21,24) BAVNYPNHVRRHET-UHFFFAOYSA-N 211971 US9290485, 3 Plasma kallikrein Human 2260 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211971&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836124 329587848 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373533 Cc1cc(N)nc(C)c1CNC(=O)c1nnc(Cc2ccccc2)o1 InChI=1S/C18H19N5O2/c1-11-8-15(19)21-12(2)14(11)10-20-17(24)18-23-22-16(25-18)9-13-6-4-3-5-7-13/h3-8H,9-10H2,1-2H3,(H2,19,21)(H,20,24) ZNFBXTCTSGUQHW-UHFFFAOYSA-N 211972 US9290485, 4 Plasma kallikrein Human 7600 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211972&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836125 329587849 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373534 Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccccc2)no1 InChI=1S/C18H19N5O2/c1-11-8-15(19)21-12(2)14(11)10-20-17(24)18-22-16(23-25-18)9-13-6-4-3-5-7-13/h3-8H,9-10H2,1-2H3,(H2,19,21)(H,20,24) AXZFTDBLZQVAAF-UHFFFAOYSA-N 211973 US9290485, 5 Plasma kallikrein Human 4500 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211973&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081292 329587850 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373535 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(Cn3cccn3)cc2)cn1 InChI=1S/C23H25N7O/c1-16-10-22(24)28-17(2)20(16)11-25-23(31)21-14-29(15-26-21)12-18-4-6-19(7-5-18)13-30-9-3-8-27-30/h3-10,14-15H,11-13H2,1-2H3,(H2,24,28)(H,25,31) OUKWTWSWNLIIED-UHFFFAOYSA-N 211974 US9290485, 6 Plasma kallikrein Human 0.2 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211974&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836188 329587851 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373536 Cc1cc(N)nc(C)c1CNC(=O)c1ncc(Cc2ccccc2)o1 InChI=1S/C19H20N4O2/c1-12-8-17(20)23-13(2)16(12)11-21-18(24)19-22-10-15(25-19)9-14-6-4-3-5-7-14/h3-8,10H,9,11H2,1-2H3,(H2,20,23)(H,21,24) CHSCMCOWGWDCQR-UHFFFAOYSA-N 211975 US9290485, 7 Plasma kallikrein Human 2030 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211975&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836192 329587852 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373537 COc1ccc(Cc2nc(co2)C(=O)NCc2c(C)cc(N)nc2C)cc1 InChI=1S/C20H22N4O3/c1-12-8-18(21)23-13(2)16(12)10-22-20(25)17-11-27-19(24-17)9-14-4-6-15(26-3)7-5-14/h4-8,11H,9-10H2,1-3H3,(H2,21,23)(H,22,25) DCMBPCSGDIXGHI-UHFFFAOYSA-N 211976 US9290485, 8 Plasma kallikrein Human 2640 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211976&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836123 329587853 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373538 COc1cc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)ccc1Cn1cccn1 InChI=1S/C24H27N7O2/c1-16-9-23(25)29-17(2)21(16)12-26-24(32)20-11-28-31(15-20)13-18-5-6-19(22(10-18)33-3)14-30-8-4-7-27-30/h4-11,15H,12-14H2,1-3H3,(H2,25,29)(H,26,32) GISSAZULDJGQMV-UHFFFAOYSA-N 211977 US9290485, 9 Plasma kallikrein Human 0.0912 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211977&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836191 329587854 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373539 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(cc2)-c2ccccc2)nn1 InChI=1S/C24H24N6O/c1-16-12-23(25)27-17(2)21(16)13-26-24(31)22-15-30(29-28-22)14-18-8-10-20(11-9-18)19-6-4-3-5-7-19/h3-12,15H,13-14H2,1-2H3,(H2,25,27)(H,26,31) OIQHYMFFSWKLDO-UHFFFAOYSA-N 211978 US9290485, 10 Plasma kallikrein Human 30 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211978&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836193 329587855 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373540 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(c1)C(CO)c1ccccc1 InChI=1S/C20H23N5O2/c1-13-8-19(21)24-14(2)17(13)10-22-20(27)16-9-23-25(11-16)18(12-26)15-6-4-3-5-7-15/h3-9,11,18,26H,10,12H2,1-2H3,(H2,21,24)(H,22,27) LBJVICZKRMLNCJ-UHFFFAOYSA-N 211979 US9290485, 11 Plasma kallikrein Human 12200 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211979 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211979&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836257 329587856 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373541 COc1ccc(cc1)S(=O)(=O)n1ccc(c1)C(=O)NCc1c(C)cc(N)nc1C InChI=1S/C20H22N4O4S/c1-13-10-19(21)23-14(2)18(13)11-22-20(25)15-8-9-24(12-15)29(26,27)17-6-4-16(28-3)5-7-17/h4-10,12H,11H2,1-3H3,(H2,21,23)(H,22,25) RMZCBHPQDPGLTG-UHFFFAOYSA-N 211980 US9290485, 12 Plasma kallikrein Human 1370 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211980&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081158 329587857 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373542 COc1ccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cc1 InChI=1S/C20H23N5O2/c1-13-8-19(21)24-14(2)18(13)10-22-20(26)16-9-23-25(12-16)11-15-4-6-17(27-3)7-5-15/h4-9,12H,10-11H2,1-3H3,(H2,21,24)(H,22,26) ULUARQDPFVJPMB-UHFFFAOYSA-N 211981 US9290485, 13 Plasma kallikrein Human 150 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211981&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836258 329587858 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373543 COc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccccc2)c1 InChI=1S/C19H21N5O2/c1-13-16(17(26-2)8-18(20)23-13)10-21-19(25)15-9-22-24(12-15)11-14-6-4-3-5-7-14/h3-9,12H,10-11H2,1-2H3,(H2,20,23)(H,21,25) LNNAHRUKLVTDBH-UHFFFAOYSA-N 211982 US9290485, 14 Plasma kallikrein Human 320 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211982&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836190 329587859 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373544 Cc1nc(N)cc(OC2CCCCC2)c1CNC(=O)c1cnn(Cc2ccccc2)c1 InChI=1S/C24H29N5O2/c1-17-21(22(12-23(25)28-17)31-20-10-6-3-7-11-20)14-26-24(30)19-13-27-29(16-19)15-18-8-4-2-5-9-18/h2,4-5,8-9,12-13,16,20H,3,6-7,10-11,14-15H2,1H3,(H2,25,28)(H,26,30) ZRENHNGQWBVIAI-UHFFFAOYSA-N 211983 US9290485, 15 Plasma kallikrein Human 230 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211983&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836259 329587860 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373545 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(CO)cc2)c1 InChI=1S/C20H23N5O2/c1-13-7-19(21)24-14(2)18(13)9-22-20(27)17-8-23-25(11-17)10-15-3-5-16(12-26)6-4-15/h3-8,11,26H,9-10,12H2,1-2H3,(H2,21,24)(H,22,27) ACHRVCHEYBBWEO-UHFFFAOYSA-N 211984 US9290485, 16 Plasma kallikrein Human 150 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211984&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836189 329587861 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373546 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(CN3C(=O)CCC3=O)cc2)c1 InChI=1S/C24H26N6O3/c1-15-9-21(25)28-16(2)20(15)11-26-24(33)19-10-27-29(14-19)12-17-3-5-18(6-4-17)13-30-22(31)7-8-23(30)32/h3-6,9-10,14H,7-8,11-13H2,1-2H3,(H2,25,28)(H,26,33) OIUPJAOKWHMNEH-UHFFFAOYSA-N 211985 US9290485, 17 Plasma kallikrein Human 98 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211985&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081267 329587862 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373547 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccncc2)c1 InChI=1S/C18H20N6O/c1-12-7-17(19)23-13(2)16(12)9-21-18(25)15-8-22-24(11-15)10-14-3-5-20-6-4-14/h3-8,11H,9-10H2,1-2H3,(H2,19,23)(H,21,25) LRMLBIIGBOPUPH-UHFFFAOYSA-N 211986 US9290485, 18 Plasma kallikrein Human 1100 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211986&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081287 329587863 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373548 CNC(=O)COc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccccc2)c1 InChI=1S/C21H24N6O3/c1-14-17(18(8-19(22)26-14)30-13-20(28)23-2)10-24-21(29)16-9-25-27(12-16)11-15-6-4-3-5-7-15/h3-9,12H,10-11,13H2,1-2H3,(H2,22,26)(H,23,28)(H,24,29) BSFUNWYPRPHBQM-UHFFFAOYSA-N 211987 US9290485, 19 Plasma kallikrein Human 70 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211987&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081255 329587864 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373549 Cc1cc(N)nc(C)c1CNC(=O)c1coc(Nc2ccccc2)n1 InChI=1S/C18H19N5O2/c1-11-8-16(19)21-12(2)14(11)9-20-17(24)15-10-25-18(23-15)22-13-6-4-3-5-7-13/h3-8,10H,9H2,1-2H3,(H2,19,21)(H,20,24)(H,22,23) PEBVXZHHVAKSFQ-UHFFFAOYSA-N 211988 US9290485, 20 Plasma kallikrein Human 7400 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211988&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081340 329587865 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373550 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccccc2)nn1 InChI=1S/C18H20N6O/c1-12-8-17(19)21-13(2)15(12)9-20-18(25)16-11-24(23-22-16)10-14-6-4-3-5-7-14/h3-8,11H,9-10H2,1-2H3,(H2,19,21)(H,20,25) QVQMFVXDJUTIKG-UHFFFAOYSA-N 211989 US9290485, 21 Plasma kallikrein Human 2540 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211989&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836260 329587866 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373551 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccccc2)cn1 InChI=1S/C19H21N5O/c1-13-8-18(20)23-14(2)16(13)9-21-19(25)17-11-24(12-22-17)10-15-6-4-3-5-7-15/h3-8,11-12H,9-10H2,1-2H3,(H2,20,23)(H,21,25) FBAPNPFIJBPEIT-UHFFFAOYSA-N 211990 US9290485, 22 Plasma kallikrein Human 1700 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211990 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211990&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836327 329587867 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373552 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(Oc3ccccc3)cc2)cn1 InChI=1S/C25H25N5O2/c1-17-12-24(26)29-18(2)22(17)13-27-25(31)23-15-30(16-28-23)14-19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h3-12,15-16H,13-14H2,1-2H3,(H2,26,29)(H,27,31) GTRZDWXIXSFZSJ-UHFFFAOYSA-N 211991 US9290485, 23 Plasma kallikrein Human 9 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211991&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836330 329587868 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373553 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(cc2)-n2cccn2)cn1 InChI=1S/C22H23N7O/c1-15-10-21(23)27-16(2)19(15)11-24-22(30)20-13-28(14-25-20)12-17-4-6-18(7-5-17)29-9-3-8-26-29/h3-10,13-14H,11-12H2,1-2H3,(H2,23,27)(H,24,30) SDKNXFXFIWAGHW-UHFFFAOYSA-N 211992 US9290485, 24 Plasma kallikrein Human 238 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211992 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211992&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836329 329587869 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373554 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2csc(Nc3ccccc3)n2)c1 InChI=1S/C22H23N7OS/c1-14-8-20(23)26-15(2)19(14)10-24-21(30)16-9-25-29(11-16)12-18-13-31-22(28-18)27-17-6-4-3-5-7-17/h3-9,11,13H,10,12H2,1-2H3,(H2,23,26)(H,24,30)(H,27,28) KRVANXMIFRIDJT-UHFFFAOYSA-N 211993 US9290485, 25 Plasma kallikrein Human 109 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211993 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211993&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836262 329587870 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373555 Cc1nc(sc1Cn1cc(cn1)C(=O)NCc1c(C)cc(N)nc1C)-c1ccccc1 InChI=1S/C23H24N6OS/c1-14-9-21(24)27-15(2)19(14)11-25-22(30)18-10-26-29(12-18)13-20-16(3)28-23(31-20)17-7-5-4-6-8-17/h4-10,12H,11,13H2,1-3H3,(H2,24,27)(H,25,30) OOHSVGGUTZAFJG-UHFFFAOYSA-N 211994 US9290485, 26 Plasma kallikrein Human 19 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211994 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211994&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836261 329587871 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373556 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2csc(Cc3ccccc3)n2)c1 InChI=1S/C23H24N6OS/c1-15-8-21(24)27-16(2)20(15)11-25-23(30)18-10-26-29(12-18)13-19-14-31-22(28-19)9-17-6-4-3-5-7-17/h3-8,10,12,14H,9,11,13H2,1-2H3,(H2,24,27)(H,25,30) XXJKFEZCNLMZSU-UHFFFAOYSA-N 211995 US9290485, 27 Plasma kallikrein Human 21 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211995&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836332 329587872 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373557 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2csc(n2)C(C)(C)C)c1 InChI=1S/C20H26N6OS/c1-12-6-17(21)24-13(2)16(12)8-22-18(27)14-7-23-26(9-14)10-15-11-28-19(25-15)20(3,4)5/h6-7,9,11H,8,10H2,1-5H3,(H2,21,24)(H,22,27) XXOBCKZLTYYIFO-UHFFFAOYSA-N 211996 US9290485, 28 Plasma kallikrein Human 343 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211996 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211996&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836328 329587873 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373558 CN(C)C(=O)Cc1nc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cs1 InChI=1S/C20H25N7O2S/c1-12-5-17(21)24-13(2)16(12)8-22-20(29)14-7-23-27(9-14)10-15-11-30-18(25-15)6-19(28)26(3)4/h5,7,9,11H,6,8,10H2,1-4H3,(H2,21,24)(H,22,29) UVQHJBUGKGJWEA-UHFFFAOYSA-N 211997 US9290485, 29 Plasma kallikrein Human 248 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211997 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211997&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836331 329587874 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373559 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cn3ccccc3n2)c1 InChI=1S/C20H21N7O/c1-13-7-18(21)24-14(2)17(13)9-22-20(28)15-8-23-27(10-15)12-16-11-26-6-4-3-5-19(26)25-16/h3-8,10-11H,9,12H2,1-2H3,(H2,21,24)(H,22,28) OYLJPVORLWINFY-UHFFFAOYSA-N 211998 US9290485, 30 Plasma kallikrein Human 204 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211998 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211998&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836408 329587875 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373560 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cc3ccccc3o2)c1 InChI=1S/C21H21N5O2/c1-13-7-20(22)25-14(2)18(13)10-23-21(27)16-9-24-26(11-16)12-17-8-15-5-3-4-6-19(15)28-17/h3-9,11H,10,12H2,1-2H3,(H2,22,25)(H,23,27) YZWTUMFQPSCKHC-UHFFFAOYSA-N 211999 US9290485, 31 Plasma kallikrein Human 143 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=211999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=211999&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836622 329587876 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373561 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2coc(n2)-c2ccccc2)c1 InChI=1S/C22H22N6O2/c1-14-8-20(23)26-15(2)19(14)10-24-21(29)17-9-25-28(11-17)12-18-13-30-22(27-18)16-6-4-3-5-7-16/h3-9,11,13H,10,12H2,1-2H3,(H2,23,26)(H,24,29) URNQLIMTVRDZCM-UHFFFAOYSA-N 212000 US9290485, 32 Plasma kallikrein Human 41 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212000 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212000&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836623 329587877 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373562 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3[nH]cnc3c2)c1 InChI=1S/C20H21N7O/c1-12-5-19(21)26-13(2)16(12)8-22-20(28)15-7-25-27(10-15)9-14-3-4-17-18(6-14)24-11-23-17/h3-7,10-11H,8-9H2,1-2H3,(H2,21,26)(H,22,28)(H,23,24) WLIVFTPRFJQPPD-UHFFFAOYSA-N 212001 US9290485, 33 Plasma kallikrein Human 262 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212001&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836411 329587878 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373563 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ccn(C)c3c2)c1 InChI=1S/C22H24N6O/c1-14-8-21(23)26-15(2)19(14)11-24-22(29)18-10-25-28(13-18)12-16-4-5-17-6-7-27(3)20(17)9-16/h4-10,13H,11-12H2,1-3H3,(H2,23,26)(H,24,29) MHLALIQKGDASOX-UHFFFAOYSA-N 212002 US9290485, 34 Plasma kallikrein Human 46 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212002&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836409 329587879 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373564 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ncoc2-c2ccccc2)c1 InChI=1S/C22H22N6O2/c1-14-8-20(23)27-15(2)18(14)10-24-22(29)17-9-26-28(11-17)12-19-21(30-13-25-19)16-6-4-3-5-7-16/h3-9,11,13H,10,12H2,1-2H3,(H2,23,27)(H,24,29) SLKNIQINJJTWTN-UHFFFAOYSA-N 212003 US9290485, 35 Plasma kallikrein Human 3900 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212003&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836485 329587880 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373565 Cc1cc(C)n(Cc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc2)n1 InChI=1S/C25H29N7O/c1-16-9-24(26)29-19(4)23(16)12-27-25(33)22-11-28-31(15-22)13-20-5-7-21(8-6-20)14-32-18(3)10-17(2)30-32/h5-11,15H,12-14H2,1-4H3,(H2,26,29)(H,27,33) MAGLWMOZQOEIRW-UHFFFAOYSA-N 212004 US9290485, 36 Plasma kallikrein Human 0.134 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212004&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836410 329587881 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373566 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(c1)S(=O)(=O)c1cccc(c1)C#N InChI=1S/C19H18N6O3S/c1-12-6-18(21)24-13(2)17(12)10-22-19(26)15-9-23-25(11-15)29(27,28)16-5-3-4-14(7-16)8-20/h3-7,9,11H,10H2,1-2H3,(H2,21,24)(H,22,26) RFWGXKVXWYEDIE-UHFFFAOYSA-N 212005 US9290485, 37 Plasma kallikrein Human 5300 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212005&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836556 329587882 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373567 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(Oc3ccccc3)cc2)nn1 InChI=1S/C24H24N6O2/c1-16-12-23(25)27-17(2)21(16)13-26-24(31)22-15-30(29-28-22)14-18-8-10-20(11-9-18)32-19-6-4-3-5-7-19/h3-12,15H,13-14H2,1-2H3,(H2,25,27)(H,26,31) MHSBTTJCQQJZNU-UHFFFAOYSA-N 212006 US9290485, 38 Plasma kallikrein Human 19 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212006 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212006&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836412 329587883 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373568 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cccc3ccccc23)nn1 InChI=1S/C22H22N6O/c1-14-10-21(23)25-15(2)19(14)11-24-22(29)20-13-28(27-26-20)12-17-8-5-7-16-6-3-4-9-18(16)17/h3-10,13H,11-12H2,1-2H3,(H2,23,25)(H,24,29) NLRLSHYJGRTPLS-UHFFFAOYSA-N 212007 US9290485, 39 Plasma kallikrein Human 634 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212007&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836487 329587884 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373569 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ccccc3c2)nn1 InChI=1S/C22H22N6O/c1-14-9-21(23)25-15(2)19(14)11-24-22(29)20-13-28(27-26-20)12-16-7-8-17-5-3-4-6-18(17)10-16/h3-10,13H,11-12H2,1-2H3,(H2,23,25)(H,24,29) MBRKUBPARWQXHD-UHFFFAOYSA-N 212008 US9290485, 40 Plasma kallikrein Human 9 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212008&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836484 329587885 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373570 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(cc2)-n2cccn2)nn1 InChI=1S/C21H22N8O/c1-14-10-20(22)25-15(2)18(14)11-23-21(30)19-13-28(27-26-19)12-16-4-6-17(7-5-16)29-9-3-8-24-29/h3-10,13H,11-12H2,1-2H3,(H2,22,25)(H,23,30) WIYPUZPBXBLMSM-UHFFFAOYSA-N 212009 US9290485, 41 Plasma kallikrein Human 108 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212009 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212009&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836553 329587886 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373571 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cccc(c2)-n2cccn2)nn1 InChI=1S/C21H22N8O/c1-14-9-20(22)25-15(2)18(14)11-23-21(30)19-13-28(27-26-19)12-16-5-3-6-17(10-16)29-8-4-7-24-29/h3-10,13H,11-12H2,1-2H3,(H2,22,25)(H,23,30) BCZGTKJOMVDJJZ-UHFFFAOYSA-N 212010 US9290485, 42 Plasma kallikrein Human 145 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212010&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836557 329587887 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373572 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cccc(c2)N2CCCC2)nn1 InChI=1S/C22H27N7O/c1-15-10-21(23)25-16(2)19(15)12-24-22(30)20-14-29(27-26-20)13-17-6-5-7-18(11-17)28-8-3-4-9-28/h5-7,10-11,14H,3-4,8-9,12-13H2,1-2H3,(H2,23,25)(H,24,30) YRTJJYKZLPYTIN-UHFFFAOYSA-N 212011 US9290485, 43 Plasma kallikrein Human 113 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212011&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836483 329587888 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373573 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cc3ccccc3o2)n1 InChI=1S/C20H20N6O2/c1-12-7-19(21)24-13(2)16(12)9-22-20(27)17-10-23-26(25-17)11-15-8-14-5-3-4-6-18(14)28-15/h3-8,10H,9,11H2,1-2H3,(H2,21,24)(H,22,27) UNTRPEXZLPRKLH-UHFFFAOYSA-N 212012 US9290485, 44 Plasma kallikrein Human 215 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212012&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836413 329587889 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373574 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc(Cn3ccnc3)cc2)nn1 InChI=1S/C22H24N8O/c1-15-9-21(23)26-16(2)19(15)10-25-22(31)20-13-30(28-27-20)12-18-5-3-17(4-6-18)11-29-8-7-24-14-29/h3-9,13-14H,10-12H2,1-2H3,(H2,23,26)(H,25,31) HHSFVRDDLHLDJJ-UHFFFAOYSA-N 212013 US9290485, 45 Plasma kallikrein Human 45 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212013 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212013&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836554 329587890 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373575 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cccc(Cn3ccnc3)c2)nn1 InChI=1S/C22H24N8O/c1-15-8-21(23)26-16(2)19(15)10-25-22(31)20-13-30(28-27-20)12-18-5-3-4-17(9-18)11-29-7-6-24-14-29/h3-9,13-14H,10-12H2,1-2H3,(H2,23,26)(H,25,31) JNYWMWTXMOIBGI-UHFFFAOYSA-N 212014 US9290485, 46 Plasma kallikrein Human 1100 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212014 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212014&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836486 329587891 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373576 Cc1cc(N)nc(C)c1CNC(=O)c1csc(Cc2ccccc2)n1 InChI=1S/C19H20N4OS/c1-12-8-17(20)22-13(2)15(12)10-21-19(24)16-11-25-18(23-16)9-14-6-4-3-5-7-14/h3-8,11H,9-10H2,1-2H3,(H2,20,22)(H,21,24) PHYSWHLTJDIWFC-UHFFFAOYSA-N 212015 US9290485, 47 Plasma kallikrein Human 3200 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212015&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836555 329587892 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373577 Cc1cc(N)nc(C)c1CNC(=O)c1ccc(Oc2ccccc2)o1 InChI=1S/C19H19N3O3/c1-12-10-17(20)22-13(2)15(12)11-21-19(23)16-8-9-18(25-16)24-14-6-4-3-5-7-14/h3-10H,11H2,1-2H3,(H2,20,22)(H,21,23) GTGHMBBKODSHRE-UHFFFAOYSA-N 212016 US9290485, 48 Plasma kallikrein Human 35500 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212016 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212016&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836488 329587893 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373578 Cc1nn(Cc2ccccc2)cc1C(=O)NCc1c(C)cc(N)nc1C InChI=1S/C20H23N5O/c1-13-9-19(21)23-14(2)17(13)10-22-20(26)18-12-25(24-15(18)3)11-16-7-5-4-6-8-16/h4-9,12H,10-11H2,1-3H3,(H2,21,23)(H,22,26) NOUMDPPDURVRDC-UHFFFAOYSA-N 212017 US9290485, 49 Plasma kallikrein Human 679 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212017&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836552 329587894 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373579 Cc1cc(C(=O)NCc2c(C)cc(N)nc2C)c(C)n1Cc1ccco1 InChI=1S/C20H24N4O2/c1-12-8-19(21)23-14(3)18(12)10-22-20(25)17-9-13(2)24(15(17)4)11-16-6-5-7-26-16/h5-9H,10-11H2,1-4H3,(H2,21,23)(H,22,25) RPXMSPHMCUCZNH-UHFFFAOYSA-N 212018 US9290485, 50 Plasma kallikrein Human 739 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212018 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212018&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836781 329587895 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373580 CC(c1ccccc1)n1c(C)cc(C(=O)NCc2c(C)cc(N)nc2C)c1C InChI=1S/C23H28N4O/c1-14-11-22(24)26-16(3)21(14)13-25-23(28)20-12-15(2)27(18(20)5)17(4)19-9-7-6-8-10-19/h6-12,17H,13H2,1-5H3,(H2,24,26)(H,25,28) JRMWHJBSUIUNBW-UHFFFAOYSA-N 212019 US9290485, 51 Plasma kallikrein Human 7000 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212019&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836782 329587896 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373581 Cc1cc(N)nc(C)c1CNC(=O)c1cc(c[nH]1)S(=O)(=O)N1CCOCC1 InChI=1S/C17H23N5O4S/c1-11-7-16(18)21-12(2)14(11)10-20-17(23)15-8-13(9-19-15)27(24,25)22-3-5-26-6-4-22/h7-9,19H,3-6,10H2,1-2H3,(H2,18,21)(H,20,23) ILFBOPLUPHMIDD-UHFFFAOYSA-N 212020 US9290485, 52 Plasma kallikrein Human 5700 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212020 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212020&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081279 329587897 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373582 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2c(F)cccc2F)nn1 InChI=1S/C18H18F2N6O/c1-10-6-17(21)23-11(2)12(10)7-22-18(27)16-9-26(25-24-16)8-13-14(19)4-3-5-15(13)20/h3-6,9H,7-8H2,1-2H3,(H2,21,23)(H,22,27) YLDIKIAHQGCTTE-UHFFFAOYSA-N 212021 US9290485, 53 Plasma kallikrein Human 3600 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212021 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212021&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836783 329587898 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373583 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2cccc(c2)C#N)nn1 InChI=1S/C19H19N7O/c1-12-6-18(21)23-13(2)16(12)9-22-19(27)17-11-26(25-24-17)10-15-5-3-4-14(7-15)8-20/h3-7,11H,9-10H2,1-2H3,(H2,21,23)(H,22,27) RFUVSHLZUAOYPH-UHFFFAOYSA-N 212022 US9290485, 54 Plasma kallikrein Human 1800 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212022 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212022&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836624 329587899 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373584 Cc1nc(Cc2ccccc2)sc1C(=O)NCc1c(C)cc(N)nc1C InChI=1S/C20H22N4OS/c1-12-9-17(21)23-13(2)16(12)11-22-20(25)19-14(3)24-18(26-19)10-15-7-5-4-6-8-15/h4-9H,10-11H2,1-3H3,(H2,21,23)(H,22,25) JEFVBYDUOMVLHI-UHFFFAOYSA-N 212023 US9290485, 55 Plasma kallikrein Human 6300 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212023&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836626 329587900 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373585 Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccccc2)n1 InChI=1S/C18H20N6O/c1-12-8-16(19)22-13(2)15(12)9-20-18(25)17-21-11-24(23-17)10-14-6-4-3-5-7-14/h3-8,11H,9-10H2,1-2H3,(H2,19,22)(H,20,25) VDVDOLCDTIHJHO-UHFFFAOYSA-N 212024 US9290485, 56 Plasma kallikrein Human 4400 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212024 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212024&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836709 329587901 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373586 Cc1cncc(Oc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc2)n1 InChI=1S/C24H25N7O2/c1-15-8-22(25)30-17(3)21(15)11-27-24(32)19-10-28-31(14-19)13-18-4-6-20(7-5-18)33-23-12-26-9-16(2)29-23/h4-10,12,14H,11,13H2,1-3H3,(H2,25,30)(H,27,32) LMKPUGVRQMCJJU-UHFFFAOYSA-N 212025 US9290485, 57 Plasma kallikrein Human 144 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212025&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836625 329587902 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373587 Cc1cc(N)nc(C)c1CNC(=O)c1coc(Cc2ccccc2)n1 InChI=1S/C19H20N4O2/c1-12-8-17(20)22-13(2)15(12)10-21-19(24)16-11-25-18(23-16)9-14-6-4-3-5-7-14/h3-8,11H,9-10H2,1-2H3,(H2,20,22)(H,21,24) HQQHQZXVVZJXRZ-UHFFFAOYSA-N 212026 US9290485, 58 Plasma kallikrein Human 3800 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212026 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212026&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836708 329587903 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373588 Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccc(Cn3cncn3)cc2)n1 InChI=1S/C21H23N9O/c1-14-7-19(22)27-15(2)18(14)8-24-21(31)20-25-13-30(28-20)10-17-5-3-16(4-6-17)9-29-12-23-11-26-29/h3-7,11-13H,8-10H2,1-2H3,(H2,22,27)(H,24,31) FUJWXPYTYXJWOD-UHFFFAOYSA-N 212027 US9290485, 59 Plasma kallikrein Human 209 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212027&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836707 329587904 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373589 COCCOc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccccc2)c1 InChI=1S/C21H25N5O3/c1-15-18(19(10-20(22)25-15)29-9-8-28-2)12-23-21(27)17-11-24-26(14-17)13-16-6-4-3-5-7-16/h3-7,10-11,14H,8-9,12-13H2,1-2H3,(H2,22,25)(H,23,27) ZUXZPMVAQHMLQJ-UHFFFAOYSA-N 212028 US9290485, 60 Plasma kallikrein Human 379 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212028 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212028&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836704 329587905 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373590 Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccc(cc2)-c2ccccc2)n1 InChI=1S/C24H24N6O/c1-16-12-22(25)28-17(2)21(16)13-26-24(31)23-27-15-30(29-23)14-18-8-10-20(11-9-18)19-6-4-3-5-7-19/h3-12,15H,13-14H2,1-2H3,(H2,25,28)(H,26,31) KHZULTQYMYJBPY-UHFFFAOYSA-N 212029 US9290485, 61 Plasma kallikrein Human 46 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212029 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212029&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836627 329587906 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373591 Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2cccc3ccccc23)n1 InChI=1S/C22H22N6O/c1-14-10-20(23)26-15(2)19(14)11-24-22(29)21-25-13-28(27-21)12-17-8-5-7-16-6-3-4-9-18(16)17/h3-10,13H,11-12H2,1-2H3,(H2,23,26)(H,24,29) VFUVLOZRLJAPPU-UHFFFAOYSA-N 212030 US9290485, 62 Plasma kallikrein Human 681 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212030&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836705 329587907 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373592 Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccc(Oc3ccccc3)cc2)n1 InChI=1S/C24H24N6O2/c1-16-12-22(25)28-17(2)21(16)13-26-24(31)23-27-15-30(29-23)14-18-8-10-20(11-9-18)32-19-6-4-3-5-7-19/h3-12,15H,13-14H2,1-2H3,(H2,25,28)(H,26,31) QVIJKFUZGKPKSV-UHFFFAOYSA-N 212031 US9290485, 63 Plasma kallikrein Human 11 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212031 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212031&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836706 329587908 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373593 Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccc3ccccc3c2)n1 InChI=1S/C22H22N6O/c1-14-9-20(23)26-15(2)19(14)11-24-22(29)21-25-13-28(27-21)12-16-7-8-17-5-3-4-6-18(17)10-16/h3-10,13H,11-12H2,1-2H3,(H2,23,26)(H,24,29) BOINRHSOFVSNQU-UHFFFAOYSA-N 212032 US9290485, 64 Plasma kallikrein Human 14 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212032 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212032&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836929 329587909 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373594 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(cc2)N2CCCC2=O)c1 InChI=1S/C23H26N6O2/c1-15-10-21(24)27-16(2)20(15)12-25-23(31)18-11-26-28(14-18)13-17-5-7-19(8-6-17)29-9-3-4-22(29)30/h5-8,10-11,14H,3-4,9,12-13H2,1-2H3,(H2,24,27)(H,25,31) YSBPDXVFLIPXTO-UHFFFAOYSA-N 212033 US9290485, 65 Plasma kallikrein Human 29 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212033 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212033&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836930 329587910 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373595 Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2ccc(cc2)-n2cccn2)n1 InChI=1S/C21H22N8O/c1-14-10-19(22)26-15(2)18(14)11-23-21(30)20-24-13-28(27-20)12-16-4-6-17(7-5-16)29-9-3-8-25-29/h3-10,13H,11-12H2,1-2H3,(H2,22,26)(H,23,30) FWDWMFHWEGGMGL-UHFFFAOYSA-N 212034 US9290485, 66 Plasma kallikrein Human 325 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212034 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212034&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835797 329587911 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373596 Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2cccc(c2)-n2cccn2)n1 InChI=1S/C21H22N8O/c1-14-9-19(22)26-15(2)18(14)11-23-21(30)20-24-13-28(27-20)12-16-5-3-6-17(10-16)29-8-4-7-25-29/h3-10,13H,11-12H2,1-2H3,(H2,22,26)(H,23,30) QXYBMUQNHRDNIX-UHFFFAOYSA-N 212035 US9290485, 67 Plasma kallikrein Human 60 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212035 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212035&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836786 329587912 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373597 Cc1cc(N)nc(C)c1CNC(=O)c1ncn(Cc2cccc(c2)N2CCCC2)n1 InChI=1S/C22H27N7O/c1-15-10-20(23)26-16(2)19(15)12-24-22(30)21-25-14-29(27-21)13-17-6-5-7-18(11-17)28-8-3-4-9-28/h5-7,10-11,14H,3-4,8-9,12-13H2,1-2H3,(H2,23,26)(H,24,30) NUMQRUYULXVQRY-UHFFFAOYSA-N 212036 US9290485, 68 Plasma kallikrein Human 34 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212036&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081301 329587913 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373598 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccnc(c2)N2CCOCC2)c1 InChI=1S/C22H27N7O2/c1-15-9-20(23)27-16(2)19(15)12-25-22(30)18-11-26-29(14-18)13-17-3-4-24-21(10-17)28-5-7-31-8-6-28/h3-4,9-11,14H,5-8,12-13H2,1-2H3,(H2,23,27)(H,25,30) GDDDMMNDJRDZCI-UHFFFAOYSA-N 212037 US9290485, 69 Plasma kallikrein Human 1600 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212037 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212037&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836784 329587914 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373599 Cc1cc(N)nc(C)c1CNC(=O)c1ccn(Cc2ccccc2)c1 InChI=1S/C20H22N4O/c1-14-10-19(21)23-15(2)18(14)11-22-20(25)17-8-9-24(13-17)12-16-6-4-3-5-7-16/h3-10,13H,11-12H2,1-2H3,(H2,21,23)(H,22,25) JYWSLTHIABTUOB-UHFFFAOYSA-N 212038 US9290485, 70 Plasma kallikrein Human 4100 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212038 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212038&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836928 329587915 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373600 COCCc1cccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)c1 InChI=1S/C22H27N5O2/c1-15-9-21(23)26-16(2)20(15)12-24-22(28)19-11-25-27(14-19)13-18-6-4-5-17(10-18)7-8-29-3/h4-6,9-11,14H,7-8,12-13H2,1-3H3,(H2,23,26)(H,24,28) VIGDTVWBASSIEN-UHFFFAOYSA-N 212039 US9290485, 71 Plasma kallikrein Human 190 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212039 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212039&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836785 329587916 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373601 Cc1cc(C(=O)NCc2c(C)cc(N)nc2C)c(C)n1S(=O)(=O)c1ccccc1 InChI=1S/C21H24N4O3S/c1-13-10-20(22)24-15(3)19(13)12-23-21(26)18-11-14(2)25(16(18)4)29(27,28)17-8-6-5-7-9-17/h5-11H,12H2,1-4H3,(H2,22,24)(H,23,26) CSWCXDDXKQWSRB-UHFFFAOYSA-N 212040 US9290485, 72 Plasma kallikrein Human 937 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212040 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212040&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836926 329587917 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373602 COc1cc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cc(OC)c1 InChI=1S/C21H25N5O3/c1-13-5-20(22)25-14(2)19(13)10-23-21(27)16-9-24-26(12-16)11-15-6-17(28-3)8-18(7-15)29-4/h5-9,12H,10-11H2,1-4H3,(H2,22,25)(H,23,27) UTAJKCOBLAFYDW-UHFFFAOYSA-N 212041 US9290485, 73 Plasma kallikrein Human 114 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212041&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836927 329587918 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373603 Cc1cn(cc1C(=O)NCc1c(C)cc(N)nc1C)S(=O)(=O)c1ccccc1 InChI=1S/C20H22N4O3S/c1-13-9-19(21)23-15(3)17(13)10-22-20(25)18-12-24(11-14(18)2)28(26,27)16-7-5-4-6-8-16/h4-9,11-12H,10H2,1-3H3,(H2,21,23)(H,22,25) BYMDCGFTGBZJBB-UHFFFAOYSA-N 212042 US9290485, 74 Plasma kallikrein Human 595 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212042 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212042&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081165 329587919 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373604 Cc1[nH]c2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc2c1C InChI=1S/C23H26N6O/c1-13-7-22(24)28-16(4)20(13)10-25-23(30)18-9-26-29(12-18)11-17-5-6-21-19(8-17)14(2)15(3)27-21/h5-9,12,27H,10-11H2,1-4H3,(H2,24,28)(H,25,30) HGVKEHICKRVVTE-UHFFFAOYSA-N 212043 US9290485, 75 Plasma kallikrein Human 3.1 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212043 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212043&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836858 329587920 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373605 Cc1cn(Cc2ccccc2)cc1C(=O)NCc1c(C)cc(N)nc1C InChI=1S/C21H24N4O/c1-14-9-20(22)24-16(3)18(14)10-23-21(26)19-13-25(11-15(19)2)12-17-7-5-4-6-8-17/h4-9,11,13H,10,12H2,1-3H3,(H2,22,24)(H,23,26) PHHWNVCZAXETDR-UHFFFAOYSA-N 212044 US9290485, 76 Plasma kallikrein Human 949 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212044&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836925 329587921 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373606 Cc1nc(N)cc(OCC(N)=O)c1CNC(=O)c1cnn(Cc2ccccc2)c1 InChI=1S/C20H22N6O3/c1-13-16(17(7-18(21)25-13)29-12-19(22)27)9-23-20(28)15-8-24-26(11-15)10-14-5-3-2-4-6-14/h2-8,11H,9-10,12H2,1H3,(H2,21,25)(H2,22,27)(H,23,28) SGCNQIHFCKWCTH-UHFFFAOYSA-N 212045 US9290485, 77 Plasma kallikrein Human 72 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212045&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081342 329587922 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373607 Cc1cc(N)nc(C)c1CNC(=O)c1coc(Oc2ccccc2)n1 InChI=1S/C18H18N4O3/c1-11-8-16(19)21-12(2)14(11)9-20-17(23)15-10-24-18(22-15)25-13-6-4-3-5-7-13/h3-8,10H,9H2,1-2H3,(H2,19,21)(H,20,23) ONJQDAWDADMDRL-UHFFFAOYSA-N 212046 US9290485, 78 Plasma kallikrein Human 10100 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212046&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081339 329587923 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373608 Cc1oc(Cn2ccc3ccccc3c2=O)cc1C(=O)NCc1c(C)cc(N)nc1C InChI=1S/C24H24N4O3/c1-14-10-22(25)27-15(2)21(14)12-26-23(29)20-11-18(31-16(20)3)13-28-9-8-17-6-4-5-7-19(17)24(28)30/h4-11H,12-13H2,1-3H3,(H2,25,27)(H,26,29) OJKPTFGDSOLUFF-UHFFFAOYSA-N 212047 US9290485, 79 Plasma kallikrein Human 166 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212047&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836861 329587924 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373609 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(OC(F)(F)F)cc2)c1 InChI=1S/C20H20F3N5O2/c1-12-7-18(24)27-13(2)17(12)9-25-19(29)15-8-26-28(11-15)10-14-3-5-16(6-4-14)30-20(21,22)23/h3-8,11H,9-10H2,1-2H3,(H2,24,27)(H,25,29) HRLLYAUDNOMZTA-UHFFFAOYSA-N 212048 US9290485, 80 Plasma kallikrein Human 117 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212048&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836860 329587925 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373610 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(c2)C#N)c1 InChI=1S/C20H20N6O/c1-13-6-19(22)25-14(2)18(13)10-23-20(27)17-9-24-26(12-17)11-16-5-3-4-15(7-16)8-21/h3-7,9,12H,10-11H2,1-2H3,(H2,22,25)(H,23,27) JKQQCHADIMQVBM-UHFFFAOYSA-N 212049 US9290485, 81 Plasma kallikrein Human 411 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212049&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836863 329587926 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373611 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(cc2)C#N)c1 InChI=1S/C20H20N6O/c1-13-7-19(22)25-14(2)18(13)10-23-20(27)17-9-24-26(12-17)11-16-5-3-15(8-21)4-6-16/h3-7,9,12H,10-11H2,1-2H3,(H2,22,25)(H,23,27) OMKHCIFLCNZFGN-UHFFFAOYSA-N 212050 US9290485, 82 Plasma kallikrein Human 678 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212050&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836862 329587927 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373612 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ccccc3c2)c1 InChI=1S/C23H23N5O/c1-15-9-22(24)27-16(2)21(15)12-25-23(29)20-11-26-28(14-20)13-17-7-8-18-5-3-4-6-19(18)10-17/h3-11,14H,12-13H2,1-2H3,(H2,24,27)(H,25,29) VWGVJQZHMBOLSQ-UHFFFAOYSA-N 212051 US9290485, 83 Plasma kallikrein Human 18 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212051&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836859 329587928 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373613 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(F)c2)c1 InChI=1S/C19H20FN5O/c1-12-6-18(21)24-13(2)17(12)9-22-19(26)15-8-23-25(11-15)10-14-4-3-5-16(20)7-14/h3-8,11H,9-10H2,1-2H3,(H2,21,24)(H,22,26) ADHPVJPGQKBDKM-UHFFFAOYSA-N 212052 US9290485, 84 Plasma kallikrein Human 498 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212052&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835993 329587929 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373614 Cc1nc(N)ccc1CNC(=O)c1cnn(Cc2ccccc2)c1 InChI=1S/C18H19N5O/c1-13-15(7-8-17(19)22-13)9-20-18(24)16-10-21-23(12-16)11-14-5-3-2-4-6-14/h2-8,10,12H,9,11H2,1H3,(H2,19,22)(H,20,24) OWFDEFYDWUKBDA-UHFFFAOYSA-N 212053 US9290485, 85 Plasma kallikrein Human 4100 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212053&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835928 329587930 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373615 Cc1cccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)n1 InChI=1S/C19H22N6O/c1-12-7-18(20)24-14(3)17(12)9-21-19(26)15-8-22-25(10-15)11-16-6-4-5-13(2)23-16/h4-8,10H,9,11H2,1-3H3,(H2,20,24)(H,21,26) CCLJREZEJQOIAB-UHFFFAOYSA-N 212054 US9290485, 86::US9290485, 99 Plasma kallikrein Human 7500 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212054 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081200 329587931 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373616 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccccc2Cl)c1 InChI=1S/C19H20ClN5O/c1-12-7-18(21)24-13(2)16(12)9-22-19(26)15-8-23-25(11-15)10-14-5-3-4-6-17(14)20/h3-8,11H,9-10H2,1-2H3,(H2,21,24)(H,22,26) ARQXIEWAUSQQHM-UHFFFAOYSA-N 212055 US9290485, 87 Plasma kallikrein Human 1300 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212055&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835799 329587932 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373617 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(CC2CCCCC2)c1 InChI=1S/C19H27N5O/c1-13-8-18(20)23-14(2)17(13)10-21-19(25)16-9-22-24(12-16)11-15-6-4-3-5-7-15/h8-9,12,15H,3-7,10-11H2,1-2H3,(H2,20,23)(H,21,25) HOPVDEHOWTWUDS-UHFFFAOYSA-N 212056 US9290485, 88 Plasma kallikrein Human 1800 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212056 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212056&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835926 329587933 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373618 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(COc3ccccc3)cc2)c1 InChI=1S/C26H27N5O2/c1-18-12-25(27)30-19(2)24(18)14-28-26(32)22-13-29-31(16-22)15-20-8-10-21(11-9-20)17-33-23-6-4-3-5-7-23/h3-13,16H,14-15,17H2,1-2H3,(H2,27,30)(H,28,32) LNIQFEDZTVICMH-UHFFFAOYSA-N 212057 US9290485, 89 Plasma kallikrein Human 6 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212057&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835798 329587934 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373619 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(F)c(F)c2)c1 InChI=1S/C19H19F2N5O/c1-11-5-18(22)25-12(2)15(11)8-23-19(27)14-7-24-26(10-14)9-13-3-4-16(20)17(21)6-13/h3-7,10H,8-9H2,1-2H3,(H2,22,25)(H,23,27) USAJQBGNUADRAW-UHFFFAOYSA-N 212058 US9290485, 90 Plasma kallikrein Human 2000 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212058&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835801 329587935 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373620 Cc1noc(n1)-c1ccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cc1 InChI=1S/C22H23N7O2/c1-13-8-20(23)26-14(2)19(13)10-24-21(30)18-9-25-29(12-18)11-16-4-6-17(7-5-16)22-27-15(3)28-31-22/h4-9,12H,10-11H2,1-3H3,(H2,23,26)(H,24,30) HIKVSELABJYTAG-UHFFFAOYSA-N 212059 US9290485, 91 Plasma kallikrein Human 133 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212059&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835800 329587936 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373621 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(Cl)c2)c1 InChI=1S/C19H20ClN5O/c1-12-6-18(21)24-13(2)17(12)9-22-19(26)15-8-23-25(11-15)10-14-4-3-5-16(20)7-14/h3-8,11H,9-10H2,1-2H3,(H2,21,24)(H,22,26) KUZFJXVHEYBFPA-UHFFFAOYSA-N 212060 US9290485, 92 Plasma kallikrein Human 867 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212060&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835922 329587937 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373622 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(F)cc2F)c1 InChI=1S/C19H19F2N5O/c1-11-5-18(22)25-12(2)16(11)8-23-19(27)14-7-24-26(10-14)9-13-3-4-15(20)6-17(13)21/h3-7,10H,8-9H2,1-2H3,(H2,22,25)(H,23,27) FFIADOLVJVDAEG-UHFFFAOYSA-N 212061 US9290485, 93 Plasma kallikrein Human 674 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212061&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835927 329587938 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373623 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(OCc3ccccc3)cc2)c1 InChI=1S/C26H27N5O2/c1-18-12-25(27)30-19(2)24(18)14-28-26(32)22-13-29-31(16-22)15-20-8-10-23(11-9-20)33-17-21-6-4-3-5-7-21/h3-13,16H,14-15,17H2,1-2H3,(H2,27,30)(H,28,32) QFRKZOVMPPMBKQ-UHFFFAOYSA-N 212062 US9290485, 94 Plasma kallikrein Human 2.1 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212062&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835923 329587939 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373624 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc3OCCCOc23)c1 InChI=1S/C22H25N5O3/c1-14-9-20(23)26-15(2)18(14)11-24-22(28)17-10-25-27(13-17)12-16-5-3-6-19-21(16)30-8-4-7-29-19/h3,5-6,9-10,13H,4,7-8,11-12H2,1-2H3,(H2,23,26)(H,24,28) UQNKWXZAHWAEIU-UHFFFAOYSA-N 212063 US9290485, 95 Plasma kallikrein Human 485 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212063&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835863 329587940 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373625 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(Cl)cc2)c1 InChI=1S/C19H20ClN5O/c1-12-7-18(21)24-13(2)17(12)9-22-19(26)15-8-23-25(11-15)10-14-3-5-16(20)6-4-14/h3-8,11H,9-10H2,1-2H3,(H2,21,24)(H,22,26) LPFUKCAHGQSIMR-UHFFFAOYSA-N 212064 US9290485, 96 Plasma kallikrein Human 291 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212064&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835925 329587941 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373626 Cc1nc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cs1 InChI=1S/C17H20N6OS/c1-10-4-16(18)21-11(2)15(10)6-19-17(24)13-5-20-23(7-13)8-14-9-25-12(3)22-14/h4-5,7,9H,6,8H2,1-3H3,(H2,18,21)(H,19,24) MGSHKJBZVVLKLV-UHFFFAOYSA-N 212065 US9290485, 97 Plasma kallikrein Human 1900 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212065&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835924 329587942 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373627 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccnc2)c1 InChI=1S/C18H20N6O/c1-12-6-17(19)23-13(2)16(12)9-21-18(25)15-8-22-24(11-15)10-14-4-3-5-20-7-14/h3-8,11H,9-10H2,1-2H3,(H2,19,23)(H,21,25) UQJLGQSSCJBZFY-UHFFFAOYSA-N 212066 US9290485, 98 Plasma kallikrein Human 3800 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212066&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835858 329587943 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373628 Cc1cccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)n1 InChI=1S/C19H22N6O/c1-12-7-18(20)24-14(3)17(12)9-21-19(26)15-8-22-25(10-15)11-16-6-4-5-13(2)23-16/h4-8,10H,9,11H2,1-3H3,(H2,20,24)(H,21,26) CCLJREZEJQOIAB-UHFFFAOYSA-N 212054 US9290485, 86::US9290485, 99 Plasma kallikrein Human 7000 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212054 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212054&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081200 329587931 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373629 CC(c1ccccc1)n1cc(cn1)C(=O)NCc1c(C)cc(N)nc1C InChI=1S/C20H23N5O/c1-13-9-19(21)24-14(2)18(13)11-22-20(26)17-10-23-25(12-17)15(3)16-7-5-4-6-8-16/h4-10,12,15H,11H2,1-3H3,(H2,21,24)(H,22,26) DTLRUZKFZYHOBO-UHFFFAOYSA-N 212068 US9290485, 100 Plasma kallikrein Human 642 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212068&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835860 329587944 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373630 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3n(C)nnc3c2)c1 InChI=1S/C20H22N8O/c1-12-6-19(21)24-13(2)16(12)9-22-20(29)15-8-23-28(11-15)10-14-4-5-18-17(7-14)25-26-27(18)3/h4-8,11H,9-10H2,1-3H3,(H2,21,24)(H,22,29) XBPJTCIEOJFPKF-UHFFFAOYSA-N 212069 US9290485, 101 Plasma kallikrein Human 70 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212069&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835859 329587945 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373631 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(c2)C(N)=O)c1 InChI=1S/C20H22N6O2/c1-12-6-18(21)25-13(2)17(12)9-23-20(28)16-8-24-26(11-16)10-14-4-3-5-15(7-14)19(22)27/h3-8,11H,9-10H2,1-2H3,(H2,21,25)(H2,22,27)(H,23,28) GHBUWRIQURZTTE-UHFFFAOYSA-N 212070 US9290485, 102 Plasma kallikrein Human 4000 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212070&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081345 329587946 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373632 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3OCOc3c2)c1 InChI=1S/C20H21N5O3/c1-12-5-19(21)24-13(2)16(12)8-22-20(26)15-7-23-25(10-15)9-14-3-4-17-18(6-14)28-11-27-17/h3-7,10H,8-9,11H2,1-2H3,(H2,21,24)(H,22,26) YZMKHZZIPJZJTR-UHFFFAOYSA-N 212071 US9290485, 103 Plasma kallikrein Human 299 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212071&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081321 329587947 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373633 Cc1cc(N)nc(C)c1CNC(=O)C1=CN(Cc2nc3ccccc3nc2C)NC1 InChI=1S/C22H25N7O/c1-13-8-21(23)27-14(2)17(13)10-24-22(30)16-9-25-29(11-16)12-20-15(3)26-18-6-4-5-7-19(18)28-20/h4-8,11,25H,9-10,12H2,1-3H3,(H2,23,27)(H,24,30) HEGIOVVAOMIEIX-UHFFFAOYSA-N 212072 US9290485, 104 Plasma kallikrein Human 113 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212072&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081207 329587948 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373634 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2nc3ccccc3s2)c1 InChI=1S/C20H20N6OS/c1-12-7-18(21)24-13(2)15(12)9-22-20(27)14-8-23-26(10-14)11-19-25-16-5-3-4-6-17(16)28-19/h3-8,10H,9,11H2,1-2H3,(H2,21,24)(H,22,27) JYZQONPRENTMRB-UHFFFAOYSA-N 212073 US9290485, 105 Plasma kallikrein Human 168 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212073&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723764 329587949 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373635 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2noc3ccccc23)c1 InChI=1S/C20H20N6O2/c1-12-7-19(21)24-13(2)16(12)9-22-20(27)14-8-23-26(10-14)11-17-15-5-3-4-6-18(15)28-25-17/h3-8,10H,9,11H2,1-2H3,(H2,21,24)(H,22,27) JYXGVWDNVCBLEQ-UHFFFAOYSA-N 212074 US9290485, 106 Plasma kallikrein Human 415 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212074&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723614 329587950 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373636 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccccc2C#N)c2ccccc12 InChI=1S/C25H23N5O/c1-16-11-24(27)29-17(2)21(16)13-28-25(31)22-15-30(23-10-6-5-9-20(22)23)14-19-8-4-3-7-18(19)12-26/h3-11,15H,13-14H2,1-2H3,(H2,27,29)(H,28,31) WKOPMVAENVMDCB-UHFFFAOYSA-N 212075 US9290485, 107 Plasma kallikrein Human 1800 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212075&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081241 329587951 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373637 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccccc2)c2ccccc12 InChI=1S/C24H24N4O/c1-16-12-23(25)27-17(2)20(16)13-26-24(29)21-15-28(14-18-8-4-3-5-9-18)22-11-7-6-10-19(21)22/h3-12,15H,13-14H2,1-2H3,(H2,25,27)(H,26,29) YPTGBOUDNLIXLS-UHFFFAOYSA-N 212076 US9290485, 108 Plasma kallikrein Human 798 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212076&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081196 329587952 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373638 Cc1cc(C(=O)NCc2c(C)cc(N)nc2C)c(C)n1Cc1ccccc1 InChI=1S/C22H26N4O/c1-14-10-21(23)25-16(3)20(14)12-24-22(27)19-11-15(2)26(17(19)4)13-18-8-6-5-7-9-18/h5-11H,12-13H2,1-4H3,(H2,23,25)(H,24,27) VGRRUJVAMGPQKT-UHFFFAOYSA-N 212077 US9290485, 109 Plasma kallikrein Human 1300 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212077&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723409 329587953 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373639 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(CN3CCOCC3)cc2)c1 InChI=1S/C24H30N6O2/c1-17-11-23(25)28-18(2)22(17)13-26-24(31)21-12-27-30(16-21)15-20-5-3-19(4-6-20)14-29-7-9-32-10-8-29/h3-6,11-12,16H,7-10,13-15H2,1-2H3,(H2,25,28)(H,26,31) KKNGSIWKXILPAS-UHFFFAOYSA-N 212078 US9290485, 110 Plasma kallikrein Human 249 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212078&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081367 329587954 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373640 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(cc2)C(=O)NC2CCS(=O)(=O)C2)c1 InChI=1S/C24H28N6O4S/c1-15-9-22(25)28-16(2)21(15)11-26-23(31)19-10-27-30(13-19)12-17-3-5-18(6-4-17)24(32)29-20-7-8-35(33,34)14-20/h3-6,9-10,13,20H,7-8,11-12,14H2,1-2H3,(H2,25,28)(H,26,31)(H,29,32) KBULNAMTSRWGCU-UHFFFAOYSA-N 212079 US9290485, 111 Plasma kallikrein Human 2100 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212079&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081310 329587955 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373641 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(NC(=O)NC3CC3)cc2)c1 InChI=1S/C23H27N7O2/c1-14-9-21(24)27-15(2)20(14)11-25-22(31)17-10-26-30(13-17)12-16-3-5-18(6-4-16)28-23(32)29-19-7-8-19/h3-6,9-10,13,19H,7-8,11-12H2,1-2H3,(H2,24,27)(H,25,31)(H2,28,29,32) LMXYYMDFPJEEJA-UHFFFAOYSA-N 212080 US9290485, 112 Plasma kallikrein Human 229 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212080&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081206 329587956 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373642 Cc1cc(N)nc(C)c1CNC(=O)c1n[nH]c(Cc2ccccc2)n1 InChI=1S/C18H20N6O/c1-11-8-15(19)21-12(2)14(11)10-20-18(25)17-22-16(23-24-17)9-13-6-4-3-5-7-13/h3-8H,9-10H2,1-2H3,(H2,19,21)(H,20,25)(H,22,23,24) CJTYZSXAGJVLIH-UHFFFAOYSA-N 212081 US9290485, 113 Plasma kallikrein Human 5800 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212081&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723583 329587957 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373643 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(cc2)-c2ccncc2)c1 InChI=1S/C24H24N6O/c1-16-11-23(25)29-17(2)22(16)13-27-24(31)21-12-28-30(15-21)14-18-3-5-19(6-4-18)20-7-9-26-10-8-20/h3-12,15H,13-14H2,1-2H3,(H2,25,29)(H,27,31) KCGGXHJBWUPJKT-UHFFFAOYSA-N 212082 US9290485, 114 Plasma kallikrein Human 30 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212082&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723687 329587958 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373644 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(c2)-c2ccccc2)c1 InChI=1S/C25H25N5O/c1-17-11-24(26)29-18(2)23(17)14-27-25(31)22-13-28-30(16-22)15-19-7-6-10-21(12-19)20-8-4-3-5-9-20/h3-13,16H,14-15H2,1-2H3,(H2,26,29)(H,27,31) HIHNCZYPMFGJEZ-UHFFFAOYSA-N 212083 US9290485, 115 Plasma kallikrein Human 3.3 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212083&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723766 329587959 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373645 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(c2)S(=O)(=O)N2CCOCC2)c1 InChI=1S/C23H28N6O4S/c1-16-10-22(24)27-17(2)21(16)13-25-23(30)19-12-26-28(15-19)14-18-4-3-5-20(11-18)34(31,32)29-6-8-33-9-7-29/h3-5,10-12,15H,6-9,13-14H2,1-2H3,(H2,24,27)(H,25,30) HTWOQJUTMHGZAY-UHFFFAOYSA-N 212084 US9290485, 116 Plasma kallikrein Human 197 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212084&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081180 329587960 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373646 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(c2)C(=O)Nc2ccccc2)c1 InChI=1S/C26H26N6O2/c1-17-11-24(27)30-18(2)23(17)14-28-25(33)21-13-29-32(16-21)15-19-7-6-8-20(12-19)26(34)31-22-9-4-3-5-10-22/h3-13,16H,14-15H2,1-2H3,(H2,27,30)(H,28,33)(H,31,34) MIRDRGNIUOZRES-UHFFFAOYSA-N 212085 US9290485, 117 Plasma kallikrein Human 152 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212085&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723596 329587961 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373647 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(CN3CCCC3)cc2)c1 InChI=1S/C24H30N6O/c1-17-11-23(25)28-18(2)22(17)13-26-24(31)21-12-27-30(16-21)15-20-7-5-19(6-8-20)14-29-9-3-4-10-29/h5-8,11-12,16H,3-4,9-10,13-15H2,1-2H3,(H2,25,28)(H,26,31) VRZRCOIKEHKLQS-UHFFFAOYSA-N 212086 US9290485, 118 Plasma kallikrein Human 183 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212086&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723843 329587962 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373648 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cccc(c2)C(=O)N2CCCCC2)c1 InChI=1S/C25H30N6O2/c1-17-11-23(26)29-18(2)22(17)14-27-24(32)21-13-28-31(16-21)15-19-7-6-8-20(12-19)25(33)30-9-4-3-5-10-30/h6-8,11-13,16H,3-5,9-10,14-15H2,1-2H3,(H2,26,29)(H,27,32) BVBHSYHAYCYSAG-UHFFFAOYSA-N 212087 US9290485, 119 Plasma kallikrein Human 289 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212087 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212087&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081316 329587963 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373649 CC(C)NC(=O)c1ccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cc1 InChI=1S/C23H28N6O2/c1-14(2)27-23(31)18-7-5-17(6-8-18)12-29-13-19(10-26-29)22(30)25-11-20-15(3)9-21(24)28-16(20)4/h5-10,13-14H,11-12H2,1-4H3,(H2,24,28)(H,25,30)(H,27,31) UYHOBBIURQGOSN-UHFFFAOYSA-N 212088 US9290485, 120 Plasma kallikrein Human 223 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212088&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081263 329587964 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373650 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(cc2)C(=O)N2CCOCC2)c1 InChI=1S/C24H28N6O3/c1-16-11-22(25)28-17(2)21(16)13-26-23(31)20-12-27-30(15-20)14-18-3-5-19(6-4-18)24(32)29-7-9-33-10-8-29/h3-6,11-12,15H,7-10,13-14H2,1-2H3,(H2,25,28)(H,26,31) XNEXYQNHODUCKT-UHFFFAOYSA-N 212089 US9290485, 121 Plasma kallikrein Human 369 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212089&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835862 329587965 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373651 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(cc2)C(=O)Nc2ccn(C)n2)c1 InChI=1S/C24H26N8O2/c1-15-10-21(25)28-16(2)20(15)12-26-23(33)19-11-27-32(14-19)13-17-4-6-18(7-5-17)24(34)29-22-8-9-31(3)30-22/h4-11,14H,12-13H2,1-3H3,(H2,25,28)(H,26,33)(H,29,30,34) NOWFJDCOFMTWBJ-UHFFFAOYSA-N 212090 US9290485, 122 Plasma kallikrein Human 752 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212090&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835861 329587966 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373652 Cc1cc(N)nc(C)c1CNC(=O)c1n[nH]c(n1)[C@@H](N)c1ccccc1 212091 US9290485, 123 Plasma kallikrein Human 15800 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212091&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723607 329587967 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373653 Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccc(cc2)-c2ccccc2)n[nH]1 InChI=1S/C24H24N6O/c1-15-12-21(25)27-16(2)20(15)14-26-24(31)23-28-22(29-30-23)13-17-8-10-19(11-9-17)18-6-4-3-5-7-18/h3-12H,13-14H2,1-2H3,(H2,25,27)(H,26,31)(H,28,29,30) MFSQIIIHVBIHND-UHFFFAOYSA-N 212092 US9290485, 124 Plasma kallikrein Human 71 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212092&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835996 329587968 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373654 Cc1cc(N)nc(C)c1CNC(=O)c1nc(Cc2ccc(Oc3ccccc3)cc2)n[nH]1 InChI=1S/C24H24N6O2/c1-15-12-21(25)27-16(2)20(15)14-26-24(31)23-28-22(29-30-23)13-17-8-10-19(11-9-17)32-18-6-4-3-5-7-18/h3-12H,13-14H2,1-2H3,(H2,25,27)(H,26,31)(H,28,29,30) MUXCZCRVQFQAIS-UHFFFAOYSA-N 212093 US9290485, 125 Plasma kallikrein Human 36 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212093&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835998 329587969 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373655 CN(C)S(=O)(=O)c1ccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cc1 InChI=1S/C21H26N6O3S/c1-14-9-20(22)25-15(2)19(14)11-23-21(28)17-10-24-27(13-17)12-16-5-7-18(8-6-16)31(29,30)26(3)4/h5-10,13H,11-12H2,1-4H3,(H2,22,25)(H,23,28) JVJHGRCLLMUDAN-UHFFFAOYSA-N 212094 US9290485, 126 Plasma kallikrein Human 670 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212094&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835997 329587970 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373656 Cc1cc(N)nc(C)c1CNC(=O)c1ccn(c1)S(=O)(=O)c1ccc(cc1)-c1ccccc1 InChI=1S/C25H24N4O3S/c1-17-14-24(26)28-18(2)23(17)15-27-25(30)21-12-13-29(16-21)33(31,32)22-10-8-20(9-11-22)19-6-4-3-5-7-19/h3-14,16H,15H2,1-2H3,(H2,26,28)(H,27,30) UQGMQMRTUNUSCX-UHFFFAOYSA-N 212095 US9290485, 127 Plasma kallikrein Human 16 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212095&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723684 329587971 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373657 Cc1cc(N)nc(C)c1CNC(=O)c1ccn(c1)S(=O)(=O)c1ccc(Cl)s1 InChI=1S/C17H17ClN4O3S2/c1-10-7-15(19)21-11(2)13(10)8-20-17(23)12-5-6-22(9-12)27(24,25)16-4-3-14(18)26-16/h3-7,9H,8H2,1-2H3,(H2,19,21)(H,20,23) DOSCTASBPDFRET-UHFFFAOYSA-N 212096 US9290485, 128 Plasma kallikrein Human 301 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212096&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081208 329587972 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373658 COc1cccc(c1)S(=O)(=O)n1ccc(c1)C(=O)NCc1c(C)cc(N)nc1C InChI=1S/C20H22N4O4S/c1-13-9-19(21)23-14(2)18(13)11-22-20(25)15-7-8-24(12-15)29(26,27)17-6-4-5-16(10-17)28-3/h4-10,12H,11H2,1-3H3,(H2,21,23)(H,22,25) XBDPGGCIEKUDKJ-UHFFFAOYSA-N 212097 US9290485, 129 Plasma kallikrein Human 244 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212097&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081360 329587973 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373659 CN1CCOc2ccc(cc12)S(=O)(=O)n1ccc(c1)C(=O)NCc1c(C)cc(N)nc1C InChI=1S/C22H25N5O4S/c1-14-10-21(23)25-15(2)18(14)12-24-22(28)16-6-7-27(13-16)32(29,30)17-4-5-20-19(11-17)26(3)8-9-31-20/h4-7,10-11,13H,8-9,12H2,1-3H3,(H2,23,25)(H,24,28) KBMZZOSYJTUSCB-UHFFFAOYSA-N 212098 US9290485, 130 Plasma kallikrein Human 67 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212098&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081184 329587974 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373660 Cc1cc(N)nc(C)c1CNC(=O)c1ccn(c1)S(=O)(=O)c1ccc2n(C)ccc2c1 InChI=1S/C22H23N5O3S/c1-14-10-21(23)25-15(2)19(14)12-24-22(28)17-7-9-27(13-17)31(29,30)18-4-5-20-16(11-18)6-8-26(20)3/h4-11,13H,12H2,1-3H3,(H2,23,25)(H,24,28) WPZSHZWTNBNXEO-UHFFFAOYSA-N 212099 US9290485, 131 Plasma kallikrein Human 9 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212099&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56835995 329587975 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373661 Cc1cc(N)nc(C)c1CNC(=O)c1ccn(c1)S(=O)(=O)c1cccc(c1)-c1ncccn1 InChI=1S/C23H22N6O3S/c1-15-11-21(24)28-16(2)20(15)13-27-23(30)18-7-10-29(14-18)33(31,32)19-6-3-5-17(12-19)22-25-8-4-9-26-22/h3-12,14H,13H2,1-2H3,(H2,24,28)(H,27,30) CFNRXFVWMJQCAJ-UHFFFAOYSA-N 212100 US9290485, 132 Plasma kallikrein Human 71 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212100&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723385 329587976 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373662 Cc1cc(C)n(n1)-c1ccc(cc1)S(=O)(=O)n1ccc(c1)C(=O)NCc1c(C)cc(N)nc1C InChI=1S/C24H26N6O3S/c1-15-11-23(25)27-18(4)22(15)13-26-24(31)19-9-10-29(14-19)34(32,33)21-7-5-20(6-8-21)30-17(3)12-16(2)28-30/h5-12,14H,13H2,1-4H3,(H2,25,27)(H,26,31) OHBJDBJVZSAGFU-UHFFFAOYSA-N 212101 US9290485, 133 Plasma kallikrein Human 196 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212101&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081288 329587977 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373663 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(OCC(O)=O)cc2)c1 InChI=1S/C21H23N5O4/c1-13-7-19(22)25-14(2)18(13)9-23-21(29)16-8-24-26(11-16)10-15-3-5-17(6-4-15)30-12-20(27)28/h3-8,11H,9-10,12H2,1-2H3,(H2,22,25)(H,23,29)(H,27,28) FOEOJKNUMDSKMO-UHFFFAOYSA-N 212102 US9290485, 134 Plasma kallikrein Human 1100 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212102&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081177 329587978 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373664 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(OCC#N)cc2)c1 InChI=1S/C21H22N6O2/c1-14-9-20(23)26-15(2)19(14)11-24-21(28)17-10-25-27(13-17)12-16-3-5-18(6-4-16)29-8-7-22/h3-6,9-10,13H,8,11-12H2,1-2H3,(H2,23,26)(H,24,28) CWYCUONCOWMQFA-UHFFFAOYSA-N 212103 US9290485, 135 Plasma kallikrein Human 89 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212103&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081309 329587979 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373665 Cc1nc(N)cc(OCC(=O)C(C)(C)C)c1CNC(=O)c1cn(Cc2ccccc2)nn1 InChI=1S/C23H28N6O3/c1-15-17(19(10-21(24)26-15)32-14-20(30)23(2,3)4)11-25-22(31)18-13-29(28-27-18)12-16-8-6-5-7-9-16/h5-10,13H,11-12,14H2,1-4H3,(H2,24,26)(H,25,31) FWRKGUCVNZBFQQ-UHFFFAOYSA-N 212104 US9290485, 136 Plasma kallikrein Human 24 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212104&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081296 329587980 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373666 Cc1nc(N)cc(OCc2ncco2)c1CNC(=O)c1cn(Cc2ccccc2)nn1 InChI=1S/C21H21N7O3/c1-14-16(18(9-19(22)25-14)31-13-20-23-7-8-30-20)10-24-21(29)17-12-28(27-26-17)11-15-5-3-2-4-6-15/h2-9,12H,10-11,13H2,1H3,(H2,22,25)(H,24,29) QWLJELCBJXPMEB-UHFFFAOYSA-N 212105 US9290485, 137 Plasma kallikrein Human 127 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212105&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081334 329587981 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373667 Cc1cc(N)ncc1CNC(=O)c1cnn(Cc2ccccc2)c1 InChI=1S/C18H19N5O/c1-13-7-17(19)20-8-15(13)9-21-18(24)16-10-22-23(12-16)11-14-5-3-2-4-6-14/h2-8,10,12H,9,11H2,1H3,(H2,19,20)(H,21,24) VEZNOACNEPSKKA-UHFFFAOYSA-N 212106 US9290485, 138 Plasma kallikrein Human 62700 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212106&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081323 329587982 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373668 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(Cn3ccc(=O)[nH]3)cc2)c1 InChI=1S/C23H25N7O2/c1-15-9-21(24)27-16(2)20(15)11-25-23(32)19-10-26-30(14-19)13-18-5-3-17(4-6-18)12-29-8-7-22(31)28-29/h3-10,14H,11-13H2,1-2H3,(H2,24,27)(H,25,32)(H,28,31) XMWLUGVHOMCRDL-UHFFFAOYSA-N 212107 US9290485, 139 Plasma kallikrein Human 4.9 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212107&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081365 329587983 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373669 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(Cn3ccnn3)cc2)c1 InChI=1S/C22H24N8O/c1-15-9-21(23)27-16(2)20(15)11-24-22(31)19-10-26-30(14-19)13-18-5-3-17(4-6-18)12-29-8-7-25-28-29/h3-10,14H,11-13H2,1-2H3,(H2,23,27)(H,24,31) AWOCNKRELUFWTO-UHFFFAOYSA-N 212108 US9290485, 140 Plasma kallikrein Human 4.6 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212108&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081346 329587984 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373670 Cc1cc(=O)n(C)n1Cc1ccc(Cn2cc(cn2)C(=O)NCc2c(C)cc(N)nc2C)cc1 InChI=1S/C25H29N7O2/c1-16-9-23(26)29-18(3)22(16)12-27-25(34)21-11-28-31(15-21)13-19-5-7-20(8-6-19)14-32-17(2)10-24(33)30(32)4/h5-11,15H,12-14H2,1-4H3,(H2,26,29)(H,27,34) MBRYIDMDONOJKC-UHFFFAOYSA-N 212109 US9290485, 141 Plasma kallikrein Human 1.2 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212109&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081338 329587985 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373671 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(Cn3ccccc3=O)cc2)c1 InChI=1S/C25H26N6O2/c1-17-11-23(26)29-18(2)22(17)13-27-25(33)21-12-28-31(16-21)15-20-8-6-19(7-9-20)14-30-10-4-3-5-24(30)32/h3-12,16H,13-15H2,1-2H3,(H2,26,29)(H,27,33) LAHWWHTYCCSIGH-UHFFFAOYSA-N 212110 US9290485, 142 Plasma kallikrein Human 0.0224 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212110&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081164 329587986 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373672 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(CN3CCCC3=O)cc2)c1 InChI=1S/C24H28N6O2/c1-16-10-22(25)28-17(2)21(16)12-26-24(32)20-11-27-30(15-20)14-19-7-5-18(6-8-19)13-29-9-3-4-23(29)31/h5-8,10-11,15H,3-4,9,12-14H2,1-2H3,(H2,25,28)(H,26,32) MKNQOJGNOABDKI-UHFFFAOYSA-N 212111 US9290485, 143 Plasma kallikrein Human 2.6 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212111&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081271 329587987 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373673 Cc1nc(N)cc(Cl)c1CNC(=O)c1cnn(Cc2ccccc2)c1 InChI=1S/C18H18ClN5O/c1-12-15(16(19)7-17(20)23-12)9-21-18(25)14-8-22-24(11-14)10-13-5-3-2-4-6-13/h2-8,11H,9-10H2,1H3,(H2,20,23)(H,21,25) DTPXJVVBPLQWBN-UHFFFAOYSA-N 212112 US9290485, 144 Plasma kallikrein Human 42400 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212112&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081275 329587988 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373674 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc(Cn3cccn3)cc2)c1 InChI=1S/C23H25N7O/c1-16-10-22(24)28-17(2)21(16)12-25-23(31)20-11-27-30(15-20)14-19-6-4-18(5-7-19)13-29-9-3-8-26-29/h3-11,15H,12-14H2,1-2H3,(H2,24,28)(H,25,31) OINOKQVNBGAIMA-UHFFFAOYSA-N 212113 US9290485, 145 Plasma kallikrein Human 0.2 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212113&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 7SD 6O1G,6O1S 58081298 329587989 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373675 Cc1cnn(Cc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc2)c1 InChI=1S/C24H27N7O/c1-16-9-27-30(12-16)13-19-4-6-20(7-5-19)14-31-15-21(10-28-31)24(32)26-11-22-17(2)8-23(25)29-18(22)3/h4-10,12,15H,11,13-14H2,1-3H3,(H2,25,29)(H,26,32) DSOFMKFSFNBAPY-UHFFFAOYSA-N 212114 US9290485, 146 Plasma kallikrein Human 0.04 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212114&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081264 329587990 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373676 Cc1ccnn1Cc1ccc(Cn2cc(nn2)C(=O)NCc2c(C)cc(N)nc2C)cc1 InChI=1S/C23H26N8O/c1-15-10-22(24)27-17(3)20(15)11-25-23(32)21-14-30(29-28-21)12-18-4-6-19(7-5-18)13-31-16(2)8-9-26-31/h4-10,14H,11-13H2,1-3H3,(H2,24,27)(H,25,32) IFSHKFMSDUJWRO-UHFFFAOYSA-N 212115 US9290485, 147 Plasma kallikrein Human 0.1 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212115&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081254 329587991 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373677 Cc1cc(C)n(Cc2ccc(Cn3cc(nn3)C(=O)NCc3c(C)cc(N)nc3C)cc2)n1 InChI=1S/C24H28N8O/c1-15-9-23(25)27-18(4)21(15)11-26-24(33)22-14-31(30-28-22)12-19-5-7-20(8-6-19)13-32-17(3)10-16(2)29-32/h5-10,14H,11-13H2,1-4H3,(H2,25,27)(H,26,33) FGZWHKYFVTWNMF-UHFFFAOYSA-N 212116 US9290485, 148 Plasma kallikrein Human 0.03 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212116&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081260 329587992 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373678 Cc1nc(N)cc(OCC(=O)C(C)(C)C)c1CNC(=O)c1cnn(Cc2ccc3ccccc3c2)c1 InChI=1S/C28H31N5O3/c1-18-23(24(12-26(29)32-18)36-17-25(34)28(2,3)4)14-30-27(35)22-13-31-33(16-22)15-19-9-10-20-7-5-6-8-21(20)11-19/h5-13,16H,14-15,17H2,1-4H3,(H2,29,32)(H,30,35) QXVKLXZLQIBRSP-UHFFFAOYSA-N 212117 US9290485, 149 Plasma kallikrein Human 7.8 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212117&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081227 329587993 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373679 COCCN1CCCc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc12 InChI=1S/C25H32N6O2/c1-17-11-24(26)29-18(2)22(17)14-27-25(32)21-13-28-31(16-21)15-19-6-7-20-5-4-8-30(9-10-33-3)23(20)12-19/h6-7,11-13,16H,4-5,8-10,14-15H2,1-3H3,(H2,26,29)(H,27,32) KEIRCROKHGIIMH-UHFFFAOYSA-N 212118 US9290485, 150 Plasma kallikrein Human 10 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212118&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081205 329587994 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373680 CN1C(=O)COc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc12 InChI=1S/C22H24N6O3/c1-13-6-20(23)26-14(2)17(13)9-24-22(30)16-8-25-28(11-16)10-15-4-5-19-18(7-15)27(3)21(29)12-31-19/h4-8,11H,9-10,12H2,1-3H3,(H2,23,26)(H,24,30) CMPHNRMQWUYGHK-UHFFFAOYSA-N 212119 US9290485, 151 Plasma kallikrein Human 13 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212119&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081195 329587995 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373681 CN1CCCc2ccc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)cc12 InChI=1S/C23H28N6O/c1-15-9-22(24)27-16(2)20(15)12-25-23(30)19-11-26-29(14-19)13-17-6-7-18-5-4-8-28(3)21(18)10-17/h6-7,9-11,14H,4-5,8,12-13H2,1-3H3,(H2,24,27)(H,25,30) WUCCRPGGMBVFRY-UHFFFAOYSA-N 212120 US9290485, 152 Plasma kallikrein Human 4 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212120&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081327 329587996 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373682 Cc1ccc2cc(Cn3cc(nn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1 InChI=1S/C22H23N7O/c1-13-8-21(23)26-15(3)18(13)10-24-22(30)20-12-29(28-27-20)11-16-5-7-19-17(9-16)6-4-14(2)25-19/h4-9,12H,10-11H2,1-3H3,(H2,23,26)(H,24,30) BYZNGWXDOMLVBH-UHFFFAOYSA-N 212121 US9290485, 153 Plasma kallikrein Human 16 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212121&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081326 329587997 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373683 Cc1ccc2cc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1 InChI=1S/C23H24N6O/c1-14-8-22(24)28-16(3)20(14)11-25-23(30)19-10-26-29(13-19)12-17-5-7-21-18(9-17)6-4-15(2)27-21/h4-10,13H,11-12H2,1-3H3,(H2,24,28)(H,25,30) AGUSXZKRBGJRHP-UHFFFAOYSA-N 212122 US9290485, 154 Plasma kallikrein Human 2 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212122&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081204 329587998 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373684 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cnc3ccccc3c2)c1 InChI=1S/C22H22N6O/c1-14-7-21(23)27-15(2)19(14)11-25-22(29)18-10-26-28(13-18)12-16-8-17-5-3-4-6-20(17)24-9-16/h3-10,13H,11-12H2,1-2H3,(H2,23,27)(H,25,29) RMYXWNNWPXHXJT-UHFFFAOYSA-N 212123 US9290485, 155 Plasma kallikrein Human 3 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212123&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081265 329587999 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373685 Cc1ccc2cc(Cn3cc(nn3)C(=O)NCc3c(C)cc(N)nc3C)cnc2c1 InChI=1S/C22H23N7O/c1-13-4-5-17-8-16(9-24-19(17)6-13)11-29-12-20(27-28-29)22(30)25-10-18-14(2)7-21(23)26-15(18)3/h4-9,12H,10-11H2,1-3H3,(H2,23,26)(H,25,30) GKNSRNKGBOLEPP-UHFFFAOYSA-N 212124 US9290485, 156 Plasma kallikrein Human 0.92 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212124&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081222 329588000 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373686 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ccc(Cl)cc3n2)c1 InChI=1S/C22H21ClN6O/c1-13-7-21(24)27-14(2)19(13)10-25-22(30)16-9-26-29(11-16)12-18-6-4-15-3-5-17(23)8-20(15)28-18/h3-9,11H,10,12H2,1-2H3,(H2,24,27)(H,25,30) NAGACJGTMZTIRV-UHFFFAOYSA-N 212125 US9290485, 157 Plasma kallikrein Human 2 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212125&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081168 329588001 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373687 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ccc(Cl)cc3n2)nn1 InChI=1S/C21H20ClN7O/c1-12-7-20(23)25-13(2)17(12)9-24-21(30)19-11-29(28-27-19)10-16-6-4-14-3-5-15(22)8-18(14)26-16/h3-8,11H,9-10H2,1-2H3,(H2,23,25)(H,24,30) GXNNDHNHDUFBEI-UHFFFAOYSA-N 212126 US9290485, 158 Plasma kallikrein Human 4 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212126&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081333 329588002 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373688 Cc1ccc2cc(Cn3cc(cn3)C(=O)NCc3ccc(N)nc3C)ccc2n1 InChI=1S/C22H22N6O/c1-14-3-5-17-9-16(4-7-20(17)26-14)12-28-13-19(11-25-28)22(29)24-10-18-6-8-21(23)27-15(18)2/h3-9,11,13H,10,12H2,1-2H3,(H2,23,27)(H,24,29) ATRKABUPNXFPKF-UHFFFAOYSA-N 212127 US9290485, 159 Plasma kallikrein Human 7 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212127&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723582 329588003 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373689 Cc1nc(N)ccc1CNC(=O)c1cnn(Cc2cc(c3cc(F)ccc3n2)C(F)(F)F)c1 InChI=1S/C22H18F4N6O/c1-12-13(2-5-20(27)30-12)8-28-21(33)14-9-29-32(10-14)11-16-7-18(22(24,25)26)17-6-15(23)3-4-19(17)31-16/h2-7,9-10H,8,11H2,1H3,(H2,27,30)(H,28,33) LRSBELBIYXLLQU-UHFFFAOYSA-N 212128 US9290485, 160 Plasma kallikrein Human 20 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212128&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081343 329588004 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373690 Cc1cc(C)c2cc(Cn3cc(cn3)C(=O)NCc3ccc(N)nc3C)c(C)nc2c1 InChI=1S/C24H26N6O/c1-14-7-15(2)21-9-19(17(4)28-22(21)8-14)12-30-13-20(11-27-30)24(31)26-10-18-5-6-23(25)29-16(18)3/h5-9,11,13H,10,12H2,1-4H3,(H2,25,29)(H,26,31) LVJONVYRGYYEGZ-UHFFFAOYSA-N 212129 US9290485, 161 Plasma kallikrein Human 4 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212129&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081359 329588005 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373691 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cc(c3cc(F)ccc3n2)C(F)(F)F)c1 InChI=1S/C23H20F4N6O/c1-12-5-21(28)31-13(2)18(12)9-29-22(34)14-8-30-33(10-14)11-16-7-19(23(25,26)27)17-6-15(24)3-4-20(17)32-16/h3-8,10H,9,11H2,1-2H3,(H2,28,31)(H,29,34) GWWXECIWSOTRAV-UHFFFAOYSA-N 212130 US9290485, 162 Plasma kallikrein Human 5 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212130&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081320 329588006 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373692 COc1ccc2cc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2c1 InChI=1S/C24H25N5O2/c1-15-8-23(25)28-16(2)22(15)12-26-24(30)20-11-27-29(14-20)13-17-4-5-19-10-21(31-3)7-6-18(19)9-17/h4-11,14H,12-13H2,1-3H3,(H2,25,28)(H,26,30) LNJDBRCEILQTPH-UHFFFAOYSA-N 212131 US9290485, 163 Plasma kallikrein Human 5 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212131&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081299 329588007 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373693 Cc1ccc2cc(Cn3cc(nn3)C(=O)NC3(CC3)c3c(C)cc(N)nc3C)ccc2n1 InChI=1S/C24H25N7O/c1-14-10-21(25)27-16(3)22(14)24(8-9-24)28-23(32)20-13-31(30-29-20)12-17-5-7-19-18(11-17)6-4-15(2)26-19/h4-7,10-11,13H,8-9,12H2,1-3H3,(H2,25,27)(H,28,32) IGVXGJBTGGNVPI-UHFFFAOYSA-N 212132 US9290485, 164 Plasma kallikrein Human 1200 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212132&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081291 329588008 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373694 Cc1nc2cc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1C InChI=1S/C22H25N7O/c1-13-7-21(23)26-14(2)18(13)10-24-22(30)17-9-25-29(12-17)11-16-5-6-20-19(8-16)27-15(3)28(20)4/h5-9,12H,10-11H2,1-4H3,(H2,23,26)(H,24,30) ZGMRJKJEDUMBBI-UHFFFAOYSA-N 212133 US9290485, 165 Plasma kallikrein Human 6 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212133&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081190 329588009 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373695 Cc1c(C)c2cc(Cn3cc(nn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1C InChI=1S/C23H27N7O/c1-13-8-22(24)26-15(3)19(13)10-25-23(31)20-12-30(28-27-20)11-17-6-7-21-18(9-17)14(2)16(4)29(21)5/h6-9,12H,10-11H2,1-5H3,(H2,24,26)(H,25,31) KXTIOXUGQMYWJG-UHFFFAOYSA-N 212134 US9290485, 166 Plasma kallikrein Human 0.2 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212134&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081259 329588010 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373696 Cc1nc(N)cc(Cl)c1CNC(=O)c1cnn(Cc2ccc(Cn3ccccc3=O)cc2)c1 InChI=1S/C24H23ClN6O2/c1-16-20(21(25)10-22(26)29-16)12-27-24(33)19-11-28-31(15-19)14-18-7-5-17(6-8-18)13-30-9-3-2-4-23(30)32/h2-11,15H,12-14H2,1H3,(H2,26,29)(H,27,33) VAWBDPGLZYEYPL-UHFFFAOYSA-N 212135 US9290485, 167 Plasma kallikrein Human 0.2 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212135&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081243 329588011 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373697 Cc1cc2cc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1C InChI=1S/C23H26N6O/c1-14-7-22(24)27-16(3)20(14)11-25-23(30)19-10-26-29(13-19)12-17-5-6-21-18(9-17)8-15(2)28(21)4/h5-10,13H,11-12H2,1-4H3,(H2,24,27)(H,25,30) IYSFGGFTJDDAJG-UHFFFAOYSA-N 212136 US9290485, 168 Plasma kallikrein Human 0.1 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212136&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081242 329588012 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373698 Cc1cn2cc(Cn3cc(cn3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1 InChI=1S/C21H23N7O/c1-13-6-19(22)26-15(3)18(13)8-23-21(29)17-7-24-28(12-17)11-16-4-5-20-25-14(2)9-27(20)10-16/h4-7,9-10,12H,8,11H2,1-3H3,(H2,22,26)(H,23,29) XFBVLADKLOFZNC-UHFFFAOYSA-N 212137 US9290485, 169 Plasma kallikrein Human 3 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212137&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081250 329588013 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373699 Cc1ccc2cc(Cc3nc(co3)C(=O)NCc3c(C)cc(N)nc3C)ccc2n1 InChI=1S/C23H23N5O2/c1-13-8-21(24)27-15(3)18(13)11-25-23(29)20-12-30-22(28-20)10-16-5-7-19-17(9-16)6-4-14(2)26-19/h4-9,12H,10-11H2,1-3H3,(H2,24,27)(H,25,29) DCCOZLDILLONDD-UHFFFAOYSA-N 212138 US9290485, 170 Plasma kallikrein Human 9.7 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212138&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081230 329588014 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373700 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2cc3ccsc3c(N)n2)c1 InChI=1S/C20H21N7OS/c1-11-5-17(21)25-12(2)16(11)8-23-20(28)14-7-24-27(9-14)10-15-6-13-3-4-29-18(13)19(22)26-15/h3-7,9H,8,10H2,1-2H3,(H2,21,25)(H2,22,26)(H,23,28) DZSUGJUGHRYZIA-UHFFFAOYSA-N 212139 US9290485, 171 Plasma kallikrein Human 26 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212139&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081335 329588015 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373701 Cc1nc(N)cc(Cl)c1CNC(=O)c1cnn(Cc2ccc3ccccc3c2)c1 InChI=1S/C22H20ClN5O/c1-14-19(20(23)9-21(24)27-14)11-25-22(29)18-10-26-28(13-18)12-15-6-7-16-4-2-3-5-17(16)8-15/h2-10,13H,11-12H2,1H3,(H2,24,27)(H,25,29) OGGNUGUPULLVNE-UHFFFAOYSA-N 212140 US9290485, 172 Plasma kallikrein Human 60 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212140&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081244 329588016 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373702 Cc1cc(NC(=O)OC(C)(C)C)nc(C)c1CNC(=O)c1cnn(Cc2ccc3ncc(Cl)cc3c2)c1 InChI=1S/C27H29ClN6O3/c1-16-8-24(33-26(36)37-27(3,4)5)32-17(2)22(16)13-30-25(35)20-11-31-34(15-20)14-18-6-7-23-19(9-18)10-21(28)12-29-23/h6-12,15H,13-14H2,1-5H3,(H,30,35)(H,32,33,36) AFGHJBPCMHFPQX-UHFFFAOYSA-N 212141 US9290485, 173 Plasma kallikrein Human 0.4 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212141&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081248 329588017 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373703 Cc1cc(N)nc(C)c1CNC(=O)c1cnn(Cc2ccc3c(CCS3(=O)=O)c2)c1 InChI=1S/C21H23N5O3S/c1-13-7-20(22)25-14(2)18(13)10-23-21(27)17-9-24-26(12-17)11-15-3-4-19-16(8-15)5-6-30(19,28)29/h3-4,7-9,12H,5-6,10-11H2,1-2H3,(H2,22,25)(H,23,27) FTBOOYITHPHSSO-UHFFFAOYSA-N 212142 US9290485, 174 Plasma kallikrein Human 75 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212142&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836061 329588018 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373704 Cc1ccc2cc(Cn3cc(nn3)C(=O)NCc3c(Cl)cc(N)nc3C)ccc2n1 InChI=1S/C21H20ClN7O/c1-12-3-5-15-7-14(4-6-18(15)25-12)10-29-11-19(27-28-29)21(30)24-9-16-13(2)26-20(23)8-17(16)22/h3-8,11H,9-10H2,1-2H3,(H2,23,26)(H,24,30) HLXKJAGGYKLWEY-UHFFFAOYSA-N 212143 US9290485, 175 Plasma kallikrein Human 61 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212143&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 56836060 329588019 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373705 Cc1c(ccn1S(=O)(=O)c1ccccc1)C(=O)NCc1c(C)cc(N)nc1C InChI=1S/C20H22N4O3S/c1-13-11-19(21)23-14(2)18(13)12-22-20(25)17-9-10-24(15(17)3)28(26,27)16-7-5-4-6-8-16/h4-11H,12H2,1-3H3,(H2,21,23)(H,22,25) SMURPCKCNPZWTD-UHFFFAOYSA-N 212144 US9290485, 176 Plasma kallikrein Human 45000 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212144&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081219 329588020 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373706 Cc1c(nnn1Cc1ccccc1)C(=O)NCc1c(C)cc(N)nc1C InChI=1S/C19H22N6O/c1-12-9-17(20)22-13(2)16(12)10-21-19(26)18-14(3)25(24-23-18)11-15-7-5-4-6-8-15/h4-9H,10-11H2,1-3H3,(H2,20,22)(H,21,26) FEWIUHKNNUCBBN-UHFFFAOYSA-N 212145 US9290485, 177 Plasma kallikrein Human 52100 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212145&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 66723765 329588021 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373707 Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ncccn2)nn1 InChI=1S/C16H18N8O/c1-10-6-14(17)21-11(2)12(10)7-20-16(25)13-8-24(23-22-13)9-15-18-4-3-5-19-15/h3-6,8H,7,9H2,1-2H3,(H2,17,21)(H,20,25) AQIFTEIUPQGAPT-UHFFFAOYSA-N 212146 US9290485, 178 Plasma kallikrein Human 67300 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212146&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081362 329588022 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373708 Cc1c(ccn1Cc1ccccc1)C(=O)NCc1c(C)cc(N)nc1C InChI=1S/C21H24N4O/c1-14-11-20(22)24-15(2)19(14)12-23-21(26)18-9-10-25(16(18)3)13-17-7-5-4-6-8-17/h4-11H,12-13H2,1-3H3,(H2,22,24)(H,23,26) DNEXVDGNWUQELI-UHFFFAOYSA-N 212147 US9290485, 179 Plasma kallikrein Human 85800 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212147&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081350 329588023 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373709 Cc1nc(N)cc(OC(F)F)c1CNC(=O)c1cnn(Cc2ccccc2)c1 InChI=1S/C19H19F2N5O2/c1-12-15(16(28-19(20)21)7-17(22)25-12)9-23-18(27)14-8-24-26(11-14)10-13-5-3-2-4-6-13/h2-8,11,19H,9-10H2,1H3,(H2,22,25)(H,23,27) QEIKRESSDYUHLL-UHFFFAOYSA-N 212148 US9290485, 180 Plasma kallikrein Human >100000 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212148&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081224 329588024 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373710 Cc1nc(N)cc(Br)c1CNC(=O)c1cnn(Cc2ccccc2)c1 InChI=1S/C18H18BrN5O/c1-12-15(16(19)7-17(20)23-12)9-21-18(25)14-8-22-24(11-14)10-13-5-3-2-4-6-13/h2-8,11H,9-10H2,1H3,(H2,20,23)(H,21,25) YOKRBWLNEMLPSA-UHFFFAOYSA-N 212149 US9290485, 181 Plasma kallikrein Human 37000 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212149&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081304 329588025 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373711 Nc1ccc(CNC(=O)c2cnn(Cc3ccccc3)c2)cn1 InChI=1S/C17H17N5O/c18-16-7-6-14(8-19-16)9-20-17(23)15-10-21-22(12-15)11-13-4-2-1-3-5-13/h1-8,10,12H,9,11H2,(H2,18,19)(H,20,23) KCWIESVYZILAHZ-UHFFFAOYSA-N 212150 US9290485, 182 Plasma kallikrein Human >100000 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212150&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081303 329588026 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 373712 Cc1c(C)n(c(C)c1C(=O)NCc1c(C)cc(N)nc1C)S(=O)(=O)c1ccccc1 InChI=1S/C22H26N4O3S/c1-13-11-20(23)25-15(3)19(13)12-24-22(27)21-14(2)16(4)26(17(21)5)30(28,29)18-9-7-6-8-10-18/h6-11H,12H2,1-5H3,(H2,23,25)(H,24,27) GXOARBSQHJYFIT-UHFFFAOYSA-N 212151 US9290485, 183 Plasma kallikrein Human >100000 7.8 25.00 C US Patent 10.7270/Q26H4G73 aid1802368 US9290485 Brandl, T; Flohr, S; Kopec, S; Lachal, J; Markert, C; Namoto, K; Nganga, P; Pirard, B; Renatus, M; Sedrani, R; Zoller, T 3/22/2016 2/6/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=212151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=212151&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 58081313 329588027 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3